Correlation Between Guardant Health and Revvity
Can any of the company-specific risk be diversified away by investing in both Guardant Health and Revvity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guardant Health and Revvity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Guardant Health and Revvity, you can compare the effects of market volatilities on Guardant Health and Revvity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guardant Health with a short position of Revvity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guardant Health and Revvity.
Diversification Opportunities for Guardant Health and Revvity
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Guardant and Revvity is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Guardant Health and Revvity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revvity and Guardant Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guardant Health are associated (or correlated) with Revvity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revvity has no effect on the direction of Guardant Health i.e., Guardant Health and Revvity go up and down completely randomly.
Pair Corralation between Guardant Health and Revvity
Allowing for the 90-day total investment horizon Guardant Health is expected to generate 2.5 times more return on investment than Revvity. However, Guardant Health is 2.5 times more volatile than Revvity. It trades about 0.44 of its potential returns per unit of risk. Revvity is currently generating about -0.15 per unit of risk. If you would invest 2,035 in Guardant Health on August 23, 2024 and sell it today you would earn a total of 1,033 from holding Guardant Health or generate 50.76% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.65% |
Values | Daily Returns |
Guardant Health vs. Revvity
Performance |
Timeline |
Guardant Health |
Revvity |
Guardant Health and Revvity Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Guardant Health and Revvity
The main advantage of trading using opposite Guardant Health and Revvity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guardant Health position performs unexpectedly, Revvity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revvity will offset losses from the drop in Revvity's long position.Guardant Health vs. Neogen | Guardant Health vs. Myriad Genetics | Guardant Health vs. Fonar | Guardant Health vs. Burning Rock Biotech |
Revvity vs. Waters | Revvity vs. IDEXX Laboratories | Revvity vs. IQVIA Holdings | Revvity vs. Charles River Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |